Investigator Initiated Trials

Thank you for your interest in Lundbeck’s Investigator Initiated Trial (IIT) program. We are proud to support the advancement of medical and scientific knowledge through independent research initiatives, including IITs, non-interventional studies and preclinical research.

IITs are defined as unsolicited, independent research where the investigator or the institution serves as the sponsor and Lundbeck provides support. The IIT support provided is either a research grant and/or supply of an investigational medicinal product (IMP), and/or validation of a study design.

Investigator Initiated Trial proposals are reviewed by a committee comprised of Lundbeck medical, regulatory and scientific personnel. Decisions are based upon scientific merit as well as alignment with research areas of interest and availability of resources. Support is awarded strictly based on research merit criteria. Support of a study does not imply any obligation toward or connection to the recommendation, referring or prescribing of Lundbeck products.

Areas of Interest
Lundbeck’s IIT program provides research grants and/or clinical supplies to eligible applicants to help address legitimate medical or scientific questions affecting the use of Lundbeck marketed products or investigational compounds. Areas of interest include the following:

For any questions not answered by viewing this website, please contact the Lundbeck IIT Team by calling 844-634-7867 or via email at Please allow at least 2-3 business days for a response to your email inquiry.

You have chosen to visit another Lundbeck website or a third-party website, which is provided as a service to you. Lundbeck does not control content on third-party websites and cannot make representations concerning the accuracy of information on every website you visit. Lundbeck is not responsible for the privacy policy of any third-party website. We encourage you to read the privacy policy of every website you visit. Click OK to continue or Cancel to return to Lundbeck.